scispace - formally typeset
D

Dominique Stoppa-Lyonnet

Researcher at Curie Institute

Publications -  444
Citations -  32995

Dominique Stoppa-Lyonnet is an academic researcher from Curie Institute. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 80, co-authored 420 publications receiving 29316 citations. Previous affiliations of Dominique Stoppa-Lyonnet include PSL Research University & Bosch.

Papers
More filters
Journal ArticleDOI

GENESIS: a French national resource to study the missing heritability of breast cancer

TL;DR: The size of the study, the availability of biological specimens and the clinical data collection together with the detailed and complete epidemiological questionnaire make this a unique national resource for investigation of the missing heritability of breast cancer, by taking into account environmental and life style factors and stratifying data on endophenotypes to decrease genetic heterogeneity.
Journal ArticleDOI

GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers

TL;DR: Both retrospective and prospective studies are still very much needed to refine individual cancer risk estimates by considering other genetic and lifestyle/environmental factors, and they will also contribute to a better understanding of the correlation between mutant BRCA1/2 alleles and phenotype.
Journal ArticleDOI

Fertility defects revealing germline biallelic nonsense NBN mutations.

TL;DR: Biological analyses revealed defects similar to those observed in NBS patients, including chromosomal instability, cellular hyperradiosensitivity and checkpoint defects as measured by radioresistant DNA synthesis (RDS).

Expertise collective inserm-fnclcc recommandations portant sur la prise en charge des femmes ayant un risque d'origine génétique de développer un cancer du sein et/ou de l'ovaire

TL;DR: In this paper, les genes les plus souvent retrouves sont BRCA1 and BRCa2, and les interventions analysees ont ete les suivantes : interventions hormonales, prevention primaire, depistage (clinique et par imagerie) and enfin le probleme de la chirurgie prophylactique.
Journal Article

Are the hereditary forms of BRCA1 and BRCA2 breast cancer sensitive to estrogens

TL;DR: Prospective studies are required to estimate the potential benefits of estrogen suppression therapies for prevention or adjuvant treatment of familial breast cancer.